InvestorsHub Logo
Followers 30
Posts 4047
Boards Moderated 0
Alias Born 07/25/2007

Re: jbog post# 16795

Monday, 02/20/2017 1:31:23 PM

Monday, February 20, 2017 1:31:23 PM

Post# of 20689

It's only recently that the FDA has been withholding approvals based on supply chain plant deficiencies.

It could be very possible that the 20mg and 40 mg suites run perfectly fine, but 10 rooms over there's a leak from a waterpipe that hasn't been fixed so the FDA will not give that plant any new business until it's satisfied the pipe is fixed.

I would doubt there's any problem with the manufacture of Glatopia, but rather there's something wrong in the plant.



Does that mean you would consider buying MNTA on on a price dip now?